[
  {
    "ts": null,
    "headline": "Morgan Stanley Downgrades Novo Nordisk A/S (NVO) from Equal-Weight to Underweight",
    "summary": "With significant revenue and dividend growth, Novo Nordisk A/S (NYSE:NVO) makes our list of the 20 Best Stocks to Buy and Hold for a Lifetime. Morgan Stanley downgraded Novo Nordisk A/S (NYSE:NVO) from Equal-Weight to Underweight on September 29, 2025, and dropped its price target from $53.20 to $42. The analyst cited a “tough path […]",
    "url": "https://finnhub.io/api/news?id=eb1acb147d75001c01456fb59f94888085eb7c4b0f7e7001cdfd8b5f9edb911d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759358790,
      "headline": "Morgan Stanley Downgrades Novo Nordisk A/S (NVO) from Equal-Weight to Underweight",
      "id": 136952141,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "With significant revenue and dividend growth, Novo Nordisk A/S (NYSE:NVO) makes our list of the 20 Best Stocks to Buy and Hold for a Lifetime. Morgan Stanley downgraded Novo Nordisk A/S (NYSE:NVO) from Equal-Weight to Underweight on September 29, 2025, and dropped its price target from $53.20 to $42. The analyst cited a “tough path […]",
      "url": "https://finnhub.io/api/news?id=eb1acb147d75001c01456fb59f94888085eb7c4b0f7e7001cdfd8b5f9edb911d"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
    "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
    "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352755,
      "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
      "id": 136951001,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
      "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
    "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
    "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352100,
      "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
      "id": 136952143,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
      "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Eli Lilly (LLY) Stock Rocketing Higher Today",
    "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 8.6% in the afternoon session after the stock's positive momentum continued as the White House revealed plans to launch a website for consumers to purchase drugs from manufacturers at a discount, providing clarity for the pharmaceutical industry on future pricing policies. The positive sentiment was bolstered by news that competitor Pfizer had already secured a deal to lower some of its U.S. drug prices. Following this, Eli Lill",
    "url": "https://finnhub.io/api/news?id=81347767ccf84273084dc94aff1d1234b7d2cd68af6035a8f8ca2ac423ab0505",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348860,
      "headline": "Why Is Eli Lilly (LLY) Stock Rocketing Higher Today",
      "id": 136952144,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 8.6% in the afternoon session after the stock's positive momentum continued as the White House revealed plans to launch a website for consumers to purchase drugs from manufacturers at a discount, providing clarity for the pharmaceutical industry on future pricing policies. The positive sentiment was bolstered by news that competitor Pfizer had already secured a deal to lower some of its U.S. drug prices. Following this, Eli Lill",
      "url": "https://finnhub.io/api/news?id=81347767ccf84273084dc94aff1d1234b7d2cd68af6035a8f8ca2ac423ab0505"
    }
  },
  {
    "ts": null,
    "headline": "Why Merck (MRK) Stock Is Up Today",
    "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.",
    "url": "https://finnhub.io/api/news?id=486fce15972b9fed8e3956ff090de0e7fa1db96758b3a92330e210d6b93ed58a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348850,
      "headline": "Why Merck (MRK) Stock Is Up Today",
      "id": 136951004,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.",
      "url": "https://finnhub.io/api/news?id=486fce15972b9fed8e3956ff090de0e7fa1db96758b3a92330e210d6b93ed58a"
    }
  },
  {
    "ts": null,
    "headline": "Trump Triggered a Rally in Drug Stocks. Why It Might Not Last.",
    "summary": "The surge in pharmaceutical stocks that followed the administration’s deal with Pfizer on Tuesday was still going strong on Wednesday.",
    "url": "https://finnhub.io/api/news?id=13f5eb24fffe0cf0e1dabf1387b42196ba46fe57fd37f6076214bb13b7713c62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759346340,
      "headline": "Trump Triggered a Rally in Drug Stocks. Why It Might Not Last.",
      "id": 136952146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The surge in pharmaceutical stocks that followed the administration’s deal with Pfizer on Tuesday was still going strong on Wednesday.",
      "url": "https://finnhub.io/api/news?id=13f5eb24fffe0cf0e1dabf1387b42196ba46fe57fd37f6076214bb13b7713c62"
    }
  },
  {
    "ts": null,
    "headline": "Market Chatter: CVS Health Introduces $200 Copay to Broaden Access to Novo Nordisk's Wegovy",
    "summary": "CVS Health's (CVS) drug benefits manager unit Caremark is offering a $200 copay for Novo Nordisk's (",
    "url": "https://finnhub.io/api/news?id=7a448799855558a9fb04ceeb5bf208adc9272594e66a158628b5ffe7fb3c9d4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759344942,
      "headline": "Market Chatter: CVS Health Introduces $200 Copay to Broaden Access to Novo Nordisk's Wegovy",
      "id": 136952147,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "CVS Health's (CVS) drug benefits manager unit Caremark is offering a $200 copay for Novo Nordisk's (",
      "url": "https://finnhub.io/api/news?id=7a448799855558a9fb04ceeb5bf208adc9272594e66a158628b5ffe7fb3c9d4c"
    }
  },
  {
    "ts": null,
    "headline": "Equities Rise Intraday as Markets Look Past Shutdown",
    "summary": "US benchmark equity indexes rose intraday as traders appeared to look past a federal government shut",
    "url": "https://finnhub.io/api/news?id=086767a9660837a406fab452a5b0cc67fe4dd2e002f497725a26a124b909e4f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759343791,
      "headline": "Equities Rise Intraday as Markets Look Past Shutdown",
      "id": 136951005,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes rose intraday as traders appeared to look past a federal government shut",
      "url": "https://finnhub.io/api/news?id=086767a9660837a406fab452a5b0cc67fe4dd2e002f497725a26a124b909e4f7"
    }
  },
  {
    "ts": null,
    "headline": "Another Surging Pharma Stock to Watch Right Now",
    "summary": "Pharmaceutical stocks have been surging the past two sessions",
    "url": "https://finnhub.io/api/news?id=81f2d37d329f244eaaa45cf23e9fd653e41654399248f524c9fa2177b9c0868c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759341210,
      "headline": "Another Surging Pharma Stock to Watch Right Now",
      "id": 136952149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks have been surging the past two sessions",
      "url": "https://finnhub.io/api/news?id=81f2d37d329f244eaaa45cf23e9fd653e41654399248f524c9fa2177b9c0868c"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY) Expands Global Reach with Orforglipron Launch Plans in India",
    "summary": "We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Eli Lilly and Company is one of them. Eli Lilly and Company (NYSE:LLY) tops our list for being one of the best healthcare stocks. It is a global biopharmaceutical leader and continues to expand its presence across diabetes, […]",
    "url": "https://finnhub.io/api/news?id=deb41a91258aecd014570e476d486558cb6f792fe6917bd4b92d61aa798aeb5c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759340807,
      "headline": "Eli Lilly and Company (LLY) Expands Global Reach with Orforglipron Launch Plans in India",
      "id": 136952150,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Eli Lilly and Company is one of them. Eli Lilly and Company (NYSE:LLY) tops our list for being one of the best healthcare stocks. It is a global biopharmaceutical leader and continues to expand its presence across diabetes, […]",
      "url": "https://finnhub.io/api/news?id=deb41a91258aecd014570e476d486558cb6f792fe6917bd4b92d61aa798aeb5c"
    }
  },
  {
    "ts": null,
    "headline": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
    "summary": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
    "url": "https://finnhub.io/api/news?id=9f9a81f312949ff19ddc70aa74d44881bfeb443dc6879b0033db0ff2c6139bbc",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759336566,
      "headline": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
      "id": 136995449,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
      "url": "https://finnhub.io/api/news?id=9f9a81f312949ff19ddc70aa74d44881bfeb443dc6879b0033db0ff2c6139bbc"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More",
    "summary": "Pharmaceutical stocks gained Wednesday afternoon amid anticipation Pfizer's deal with the Trump administration could lead to more with other firms.",
    "url": "https://finnhub.io/api/news?id=53f0874c88d2e08bf49dd7ec378ed52854f845339df094421fccff0eaa9ed8b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759336541,
      "headline": "Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More",
      "id": 136947201,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks gained Wednesday afternoon amid anticipation Pfizer's deal with the Trump administration could lead to more with other firms.",
      "url": "https://finnhub.io/api/news?id=53f0874c88d2e08bf49dd7ec378ed52854f845339df094421fccff0eaa9ed8b5"
    }
  },
  {
    "ts": null,
    "headline": "Reddit sinks on ChatGPT data, Pfizer deal boosts pharma stocks",
    "summary": "Yahoo Finance anchor Julie Hyman outlines some of the biggest stories as part of this Market Minute, including pharmaceutical stocks rising on Pfizer's (PFE) tariff deal with the Trump administration, Reddit (RDDT) stock sinking as new data shows that the number of ChatGPT's (OPAI.PVT) responses referencing Reddit content has declined, and Jefferies' bullish Sunrun (RUN) call. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=924ce6709fdd7f3299136f8a717717617a9b0625410a2b15fe550f29c27bdb05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759335450,
      "headline": "Reddit sinks on ChatGPT data, Pfizer deal boosts pharma stocks",
      "id": 136947202,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Yahoo Finance anchor Julie Hyman outlines some of the biggest stories as part of this Market Minute, including pharmaceutical stocks rising on Pfizer's (PFE) tariff deal with the Trump administration, Reddit (RDDT) stock sinking as new data shows that the number of ChatGPT's (OPAI.PVT) responses referencing Reddit content has declined, and Jefferies' bullish Sunrun (RUN) call. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=924ce6709fdd7f3299136f8a717717617a9b0625410a2b15fe550f29c27bdb05"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock, Other Drugmakers Rally Again",
    "summary": "After its best day in nearly four years Tuesday, Pfizer stock is giving an encore performance. Shares of the drugmaker are up 5.5% in midday trading as investors digest yesterday's news that Pfizer would get a three-year exemption from national-security-related tariffs, in return for domestic manufacturing investments and Pfizer's participation in a government-run website called TrumpRx.",
    "url": "https://finnhub.io/api/news?id=3d4f225276ac87a5c85b10c4e7ba33633e09007d4b366cd4c04200e8c17b96b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759333445,
      "headline": "Pfizer Stock, Other Drugmakers Rally Again",
      "id": 136947203,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "After its best day in nearly four years Tuesday, Pfizer stock is giving an encore performance. Shares of the drugmaker are up 5.5% in midday trading as investors digest yesterday's news that Pfizer would get a three-year exemption from national-security-related tariffs, in return for domestic manufacturing investments and Pfizer's participation in a government-run website called TrumpRx.",
      "url": "https://finnhub.io/api/news?id=3d4f225276ac87a5c85b10c4e7ba33633e09007d4b366cd4c04200e8c17b96b4"
    }
  },
  {
    "ts": null,
    "headline": "Q: Will TrumpRx and ‘Most Favored Nation’ Deals Save Americans Money?",
    "summary": "A: Pfizer is the first drugmaker to reach an agreement with the White House that includes selling its drugs to Medicaid at the lowest price available to other developed countries, the “most-favored-nation” price.  Most Americans enrolled in health plans will likely save more money using their insurance.  For Medicaid patients, it is unclear whether the “most favored nation” pricing will be lower than what the program currently pays.",
    "url": "https://finnhub.io/api/news?id=f87470901d1b48e64f742dd1c75e88cf230248dcd282d7a633a839623e87d40c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759330997,
      "headline": "Q: Will TrumpRx and ‘Most Favored Nation’ Deals Save Americans Money?",
      "id": 136947204,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "A: Pfizer is the first drugmaker to reach an agreement with the White House that includes selling its drugs to Medicaid at the lowest price available to other developed countries, the “most-favored-nation” price.  Most Americans enrolled in health plans will likely save more money using their insurance.  For Medicaid patients, it is unclear whether the “most favored nation” pricing will be lower than what the program currently pays.",
      "url": "https://finnhub.io/api/news?id=f87470901d1b48e64f742dd1c75e88cf230248dcd282d7a633a839623e87d40c"
    }
  },
  {
    "ts": null,
    "headline": "Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading",
    "summary": "Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading",
    "url": "https://finnhub.io/api/news?id=279c6d25b27495907ff20e46c94ee722f328cb615bb6baba85a2a6448ba0eadf",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759330136,
      "headline": "Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading",
      "id": 136995478,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading",
      "url": "https://finnhub.io/api/news?id=279c6d25b27495907ff20e46c94ee722f328cb615bb6baba85a2a6448ba0eadf"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental",
    "summary": "↗️ Lithium Americas (LAC): The U.S. government said Tuesday it would take a 5% stake in both the Canadian company and its Nevada mining project. Shares jumped by roughly one-third in premarket trading.",
    "url": "https://finnhub.io/api/news?id=0c07d91dfc9d3e0294361190c520161e7d11d3f8d6816c7d27813c5f3214b964",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759309518,
      "headline": "Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental",
      "id": 136944164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "↗️ Lithium Americas (LAC): The U.S. government said Tuesday it would take a 5% stake in both the Canadian company and its Nevada mining project. Shares jumped by roughly one-third in premarket trading.",
      "url": "https://finnhub.io/api/news?id=0c07d91dfc9d3e0294361190c520161e7d11d3f8d6816c7d27813c5f3214b964"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market News for Oct 1, 2025",
    "summary": "Wall Street closed higher on Tuesday, driven by healthcare stocks.",
    "url": "https://finnhub.io/api/news?id=692623bfe06a30c36b0e1a4cb3ee9803a2acf7c087c14079fba82ca723e204a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759324920,
      "headline": "Stock Market News for Oct 1, 2025",
      "id": 136947206,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Wall Street closed higher on Tuesday, driven by healthcare stocks.",
      "url": "https://finnhub.io/api/news?id=692623bfe06a30c36b0e1a4cb3ee9803a2acf7c087c14079fba82ca723e204a0"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma's big boost: Market Movers",
    "summary": "Pharma giants in the US had a massive boost after Pfizer (PFE) avoided tariffs by coming to an agreement with Donald Trump to sell drugs directly to the American people at a lower price. Domestic competitors Eli Lilly (LLY) and Merck (MRK) are expected to follow suit, as Pfizer also announced $70 billion dollars worth of investment in the US. The ripple effects were also felt in Europe and beyond. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.",
    "url": "https://finnhub.io/api/news?id=1ce3ee5a61ff50b2d2825bb52f238f67de975bb396f5471aa4a46561797f862a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759320182,
      "headline": "Big Pharma's big boost: Market Movers",
      "id": 136947207,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Pharma giants in the US had a massive boost after Pfizer (PFE) avoided tariffs by coming to an agreement with Donald Trump to sell drugs directly to the American people at a lower price. Domestic competitors Eli Lilly (LLY) and Merck (MRK) are expected to follow suit, as Pfizer also announced $70 billion dollars worth of investment in the US. The ripple effects were also felt in Europe and beyond. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.",
      "url": "https://finnhub.io/api/news?id=1ce3ee5a61ff50b2d2825bb52f238f67de975bb396f5471aa4a46561797f862a"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot",
    "summary": "A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.",
    "url": "https://finnhub.io/api/news?id=00f49db858a494509b37a7effcd3109370829982f3875184f265e9fd35b2747e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759314600,
      "headline": "Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot",
      "id": 136952151,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.",
      "url": "https://finnhub.io/api/news?id=00f49db858a494509b37a7effcd3109370829982f3875184f265e9fd35b2747e"
    }
  },
  {
    "ts": null,
    "headline": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
    "summary": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
    "url": "https://finnhub.io/api/news?id=a4e04cdc235f20ebb03633aa05fb75eda0611f0b148ce2199bd524b7919f032d",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759312884,
      "headline": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
      "id": 136995450,
      "image": "",
      "related": "LLY",
      "source": "DowJones",
      "summary": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
      "url": "https://finnhub.io/api/news?id=a4e04cdc235f20ebb03633aa05fb75eda0611f0b148ce2199bd524b7919f032d"
    }
  }
]